1. Home
  2. LFWD vs PHGE Comparison

LFWD vs PHGE Comparison

Compare LFWD & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFWD
  • PHGE
  • Stock Information
  • Founded
  • LFWD 2001
  • PHGE 2015
  • Country
  • LFWD Israel
  • PHGE Israel
  • Employees
  • LFWD N/A
  • PHGE N/A
  • Industry
  • LFWD
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • LFWD
  • PHGE Health Care
  • Exchange
  • LFWD NYSE
  • PHGE Nasdaq
  • Market Cap
  • LFWD 10.5M
  • PHGE 11.0M
  • IPO Year
  • LFWD 2014
  • PHGE N/A
  • Fundamental
  • Price
  • LFWD $0.78
  • PHGE $0.43
  • Analyst Decision
  • LFWD Strong Buy
  • PHGE Strong Buy
  • Analyst Count
  • LFWD 3
  • PHGE 1
  • Target Price
  • LFWD $9.00
  • PHGE $15.00
  • AVG Volume (30 Days)
  • LFWD 804.6K
  • PHGE 3.1M
  • Earning Date
  • LFWD 08-14-2025
  • PHGE 08-13-2025
  • Dividend Yield
  • LFWD N/A
  • PHGE N/A
  • EPS Growth
  • LFWD N/A
  • PHGE N/A
  • EPS
  • LFWD N/A
  • PHGE N/A
  • Revenue
  • LFWD $25,414,000.00
  • PHGE N/A
  • Revenue This Year
  • LFWD $12.04
  • PHGE N/A
  • Revenue Next Year
  • LFWD $40.58
  • PHGE N/A
  • P/E Ratio
  • LFWD N/A
  • PHGE N/A
  • Revenue Growth
  • LFWD 41.92
  • PHGE N/A
  • 52 Week Low
  • LFWD $0.50
  • PHGE $0.34
  • 52 Week High
  • LFWD $4.77
  • PHGE $2.35
  • Technical
  • Relative Strength Index (RSI)
  • LFWD 43.98
  • PHGE 48.13
  • Support Level
  • LFWD $0.70
  • PHGE $0.38
  • Resistance Level
  • LFWD $0.84
  • PHGE $0.46
  • Average True Range (ATR)
  • LFWD 0.07
  • PHGE 0.05
  • MACD
  • LFWD 0.03
  • PHGE 0.01
  • Stochastic Oscillator
  • LFWD 44.88
  • PHGE 16.76

About LFWD REWALK ROBOTICS LTD

Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: